###begin article-title 0
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
Absence of ERRalpha in Female Mice Confers Resistance to Bone Loss Induced by Age or Estrogen-Deficiency
###end article-title 0
###begin p 1
Conceived and designed the experiments: MCS OC JMV. Performed the experiments: CT MG BR LM JD CM JE BH. Analyzed the data: MCS OC JMV. Contributed reagents/materials/analysis tools: VG. Wrote the paper: MCS OC JMV.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
ERRalpha is an orphan member of the nuclear hormone receptor superfamily, which acts as a transcription factor and is involved in various metabolic processes. ERRalpha is also highly expressed in ossification zones during mouse development as well as in human bones and cell lines. Previous data have shown that this receptor up-modulates the expression of osteopontin, which acts as an inhibitor of bone mineralization and whose absence results in resistance to ovariectomy-induced bone loss. Altogether this suggests that ERRalpha may negatively regulate bone mass and could impact on bone fragility that occurs in the absence of estrogens.
###end p 3
###begin title 4
Methods/Principal Findings
###end title 4
###begin p 5
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
In this report, we have determined the in vivo effect of ERRalpha on bone, using knock-out mice. Relative to wild type animals, female ERRalphaKO bones do not age and are resistant to bone loss induced by estrogen-withdrawal. Strikingly male ERRalphaKO mice are indistinguishable from their wild type counterparts, both at the unchallenged or gonadectomized state. Using primary cell cultures originating from ERRalphaKO bone marrow, we also show that ERRalpha acts as an inhibitor of osteoblast differentiation.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
Down-regulating ERRalpha could thus be beneficial against osteoporosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Ducy1">[1]</xref>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Komori1">[3]</xref>
###xml 594 597 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Kostenuik1">[4]</xref>
###xml 598 601 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Asagiri1">[7]</xref>
###xml 874 877 870 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Simonet1">[8]</xref>
###xml 879 882 875 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Boyce1">[9]</xref>
Bone is a highly dynamic tissue subjected to active remodeling, an equilibrium between construction by osteoblasts and resorption by osteoclasts. Osteoblast are derived from mesenchymal stem cells (MSCs) and their differentiation is promoted by various factors such as the transcription factors Osterix and Runx2 [1]-[3]. Mature osteoblasts express receptor activator of nuclear factor-kappaB ligand (RANKL), a protein that will signal through RANK, a member of the tumor necrosis factor receptor superfamily present at the surface of pre-osteoclasts, and induce differentiation of these cells [4]-[7]. On another hand, osteoblasts, as well as other cell types, also express and secrete osteoprotegerin (opg), a decoy receptor that traps RANKL in the extracellular milieu, preventing it from acting on pre-osteoclasts, and thus inhibiting the differentiation of osteoclasts [8], [9].
###end p 9
###begin p 10
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Syed1">[10]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Raisz1">[11]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Raisz1">[11]</xref>
###xml 166 171 <span type="species:ncbi:9606">women</span>
Stability of bone remodeling also requires other diffusible factors among which estrogens are instrumental. This is particularly illustrated after menopause in aging women, when the fall of circulating level of estrogens leads to enhanced bone remodeling with an excessive resorption [10], [11]. The resulting osteoporosis syndrome is associated with an enhanced fracture risk. Various means are currently available to prevent and treat osteoporosis, most of which mainly aim at inhibiting the excess of bone resorption. These include for example the use of estrogens (natural or synthetic) or of bisphosphonate to reduce osteoclast differentiation or induce their apoptosis, respectively [11].
###end p 10
###begin p 11
###xml 185 189 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Laudet1">[12]</xref>
###xml 246 250 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 299 303 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Gigure1">[13]</xref>
###xml 448 452 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Gigure2">[14]</xref>
###xml 454 458 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Tremblay1">[15]</xref>
###xml 556 560 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Horard1">[16]</xref>
###xml 654 658 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bonnelye1">[17]</xref>
###xml 1285 1301 1242 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Ariazi1">[reviewed in 20]</xref>
###xml 1450 1454 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bianco1">[21]</xref>
###xml 1593 1597 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bonnelye2">[22]</xref>
###xml 1749 1753 1694 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Laflamme1">[23]</xref>
###xml 1895 1899 1836 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Reinholt1">[24]</xref>
###xml 1900 1904 1841 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Kavukcuoglu1">[30]</xref>
###xml 1972 1976 1909 1913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Vanacker1">[31]</xref>
###xml 1977 1981 1914 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Zirngibl1">[33]</xref>
###xml 1182 1187 <span type="species:ncbi:9606">human</span>
###xml 1518 1523 <span type="species:ncbi:10090">mouse</span>
###xml 1581 1586 <span type="species:ncbi:9606">human</span>
###xml 1641 1646 <span type="species:ncbi:9606">human</span>
###xml 1743 1748 <span type="species:ncbi:9606">women</span>
The effects of estrogens are mediated by two estrogen receptors (ERs) alpha and beta, which act as ligand-dependent transcription factors and belong to the nuclear receptor superfamily [12]. This family also comprises so-called orphan receptors, i.e. for which no ligand has been identified to date [13]. Estrogen-Receptor Related receptor alpha (ERRalpha) was among the first orphan receptors isolated, based on its sequence similarity to ERalpha [14], [15]. Despite this close proximity, ERRalpha does not bind estrogen nor any identified natural ligand [16]. ERRalpha is expressed in several tissues both during embryonic development and in the adult [17]. A number of studies have identified ERRalpha as a major actor in the regulation of energy metabolism in oxidative tissues such as heart or slow-twitch skeletal muscle [18, 19 for reviews]. This receptor is indeed involved in the regulation of energy uptake, storage and consumption as well as in mitochondrial biogenesis and function and cardiac response to stress. Most of these effects are thought to depend on the PGC-1alpha coactivator, with which ERRalpha physically interacts. High expression of ERRalpha in various human tumors (originating from such organ as breast, colon and ovary) correlates with a poor prognosis [reviewed in 20]. Proliferation of various cancer cell lines can be inhibited by a synthesis modulator of ERRalpha, but not by its mere siRNA-mediated knocking-down [21]. ERRalpha is highly expressed in all ossification zones during mouse development, as well as in osteoblastic lines and normal human bones [22]. Furthermore, a polymorphic variant of the human ERRalpha promoter has been associated with variable bone mineral density (BMD) in premenopausal women [23]. Although the molecular functions of ERRalpha in bone cells have not been determined, osteopontin (opn), an inhibitor of bone mineralization [24]-[30], has been identified as a positive ERRalpha transcriptional target [31]-[33].
###end p 11
###begin p 12
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Here, we show that ERRalphaKO female mice resist to age-induced bone loss and present a more elevated bone formation rate as compared to wild type animals. Remarkably, ERRalpha deficiency also conferred resistance to bone loss induced by estrogen withdrawal. Noteworthy, no phenotype was observed in the bones of ERRalpha-deficient males. ERRalphaKO originating MSCs displayed enhanced capacities to differentiate into osteoblasts, together with a lower opn expression, as compared to wt MSCs. Altogether our results reveal the role of ERRalpha in the control of bone density and suggest important cross talks between ERRalpha and hormonal signalling pathways in bone physiology.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
###xml 67 71 <span type="species:ncbi:10090">Mice</span>
ERRalpha Deficiency Affects Bone Aging in Female, but Not in Male, Mice
###end title 14
###begin p 15
###xml 305 318 301 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g001">Fig. 1A and B</xref>
###xml 524 531 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g001">Fig. 1C</xref>
###xml 571 578 563 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g001">Fig. 1D</xref>
###xml 608 615 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g001">Fig. 1E</xref>
###xml 1153 1160 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007942-t001">Table 1</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
The structural parameters of cortical and trabecular bone were measured in the femur diaphysis and metaphysis, respectively, of wild type (wt) and ERRalpha knockout female mice at 14 and 24 weeks. Cortical bone mineral density (BMD) and thickness augmented with age in a similar manner in both genotypes (Fig. 1A and B). The trabecular mineral density (TMD) was slightly more elevated (but not statistically significant) in wt animals as compared to ERRalphaKO, but significantly increased with time in the latter genotype (Fig. 1C). Lower trabecular bone volume (BV/TV; Fig. 1D) and trabecular number (TbN; Fig. 1E) were observed in ERRalphaKO animals relative to wt ones at 14 wk. Interestingly whereas these two parameters were significantly reduced at 24 wk in wt animals as an effect of age, no significant variation occurred in ERRalphaKO mice. These results indicate that ERRalphaKO female mice, although deficient in bone trabeculae at maturity (14 wk), are resistant to age-related bone loss. Strikingly no difference was observed in any of the structural parameters of both cortical and trabecular bone between wild type and mutant male mice (Table 1), indicating a gender-dependent effect of the absence of ERRalpha.
###end p 15
###begin title 16
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Bone phenotype of ERRalphaKO females mice.
###end title 16
###begin p 17
###xml 36 37 36 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
Cortical bone mineral density (BMD; A), cortical thickness (B), trabecular mineral density (TMD; C), bone volume fraction (BV/TV; D) and trabecular number (TbN; E) were determined at 14 (white bars) and 24 wk (black bars) in the femur of female wt and ERRalphaKO mice (n = 6 to 9). Errors bars represent s.e.m. ns: not significant; *:p<0.05; *** p<0.005.
###end p 17
###begin title 18
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Trabecular bone parameters of wt and ERRalphaKO male mice (n = 8 to 10).
###end title 18
###begin p 19
: orchidectomized animals.
###end p 19
###begin p 20
: trabecular mineral density.
###end p 20
###begin p 21
: bone volume/tissue volume.
###end p 21
###begin p 22
: trabecular number.
###end p 22
###begin p 23
###xml 156 160 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 357 364 349 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g002">Fig. 2A</xref>
###xml 436 443 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g002">Fig. 2B</xref>
###xml 690 697 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g002">Fig. 2C</xref>
###xml 750 757 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g002">Fig. 2D</xref>
###xml 799 806 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g002">Fig. 2E</xref>
The evolution of bone between wild type and ERRalphaKO females prompted us to examine the parameters of bone resorption and bone formation at 14 wk of age (i.e. before a significant difference could be observed between genotypes). Bone formation rate, which represent the activity of osteoblasts, was more elevated in ERRalphaKO females than in wt animals (Fig. 2A). The surface occupied by osteoblasts was identical in both genotypes (Fig. 2B). Serum markers of bone resorption (C-terminal fragment of collagen 1 [Ctx], indicative of osteoclast activity) were not different between wild type and mutant females, indicating that bone resorption was not affected by the ERRalpha deficiency (Fig. 2C). Consistently, a comparable number of osteoclasts (Fig. 2D), spaning an identical relative surface (Fig. 2E) were detected in both strains.
###end p 23
###begin title 24
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Dynamic parameters of ERRalphaKO female mice.
###end title 24
###begin p 25
###xml 26 27 26 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 144 145 144 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 304 305 304 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 356 357 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
Bone formation rate (BFR; A) and mineralizing surface per trabecular bone surface (MS/BS; B) were measured in the metaphysis of 14 wk old mice. C) Concentration of the C-terminal fragments of collagen 1 (Ctx) were measured in the serum of 14 wk old females. Osteoclast number per bone perimeter (OCn/Bp; D) and osteoclast surface per bone surface (OCs/Bs; E). n = 8. White bars: wild type; black bars: ERRalphaKO mice. Error bars represent s.e.m. ns: not significant; *:p<0.05.
###end p 25
###begin p 26
Altogether this suggests that the resistance of ERRalphaKO animals to age-induced bone loss could be due to an enhanced osteoblastic activity, and not to variation in osteoclast-related parameters.
###end p 26
###begin title 27
ERRalpha Negatively Regulates Osteoblast Differentiation
###end title 27
###begin p 28
###xml 110 117 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 288 295 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g003">Fig. 3A</xref>
###xml 628 632 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Vanacker1">[31]</xref>
###xml 633 637 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Zirngibl1">[33]</xref>
###xml 786 793 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g003">Fig. 3B</xref>
###xml 1037 1044 1005 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g003">Fig. 3C</xref>
###xml 1757 1764 1705 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g003">Fig. 3D</xref>
###xml 2341 2345 2273 2277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bianco1">[21]</xref>
###xml 2455 2459 2383 2387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bonnelye3">[34]</xref>
###xml 2570 2574 2498 2502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 2660 2664 2584 2588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Bonnelye3">[34]</xref>
###xml 3037 3041 2957 2961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Delhon1">[35]</xref>
###xml 3442 3450 3354 3362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3498 3505 3410 3417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 3505 3509 3417 3421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Jeong1">[36]</xref>
###xml 3547 3554 3459 3466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 3641 3648 3549 3556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 3732 3736 3636 3640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Reinholt1">[24]</xref>
###xml 3737 3741 3641 3645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Kavukcuoglu1">[30]</xref>
###xml 2630 2634 <span type="species:ncbi:10090">mice</span>
###xml 2694 2697 <span type="species:ncbi:10116">rat</span>
###xml 3663 3667 <span type="species:ncbi:10090">mice</span>
###xml 3877 3881 <span type="species:ncbi:10090">mice</span>
We thus analyzed the capacities of ERRalphaKO bone marrow mesenchymal cells to differentiate into osteoblasts ex vivo. After seven days in the appropriate medium, ERRalpha mutant cells produced a greater number of differentiation foci as estimated by alkaline phosphatase (ALP) staining (Fig. 3A). This was accompanied by a higher mineralization activity, as revealed by von Kossa staining. As measured by quantitative PCR, the expression of various osteoblast differentiation markers, such as Runx-2, ALP or osteocalcin was found more elevated in ERRalphaKO cells by quantitative PCR. In contrast, opn, an ERRalpha target gene [31]-[33], was less expressed in ERRalphaKO cells than in wild type cells. We also analyzed the kinetics of ALP expression during osteoblast differentiation (Fig. 3B). In ERRalphaKO cells, ALP expression followed the same profile as in wild-type cells but was more elevated at each time point. The phenotype displayed by mutant cells was rescued by infection with an ERRalpha-encoding adenovirus (AdERRalpha; Fig. 3C). Indeed, ALP staining was reduced by AdERRalpha infection as compared to cells infected with a GFP-encoding adenovirus. AdERRalpha also reduced the mRNA expression of Runx-2, ALP and osteocalcin. This repression was not a general, non-specific phenomenon since osteopontin expression was enhanced by AdERRalpha, as expected. This suggests that the capacities of MSCs to differentiate into osteoblasts are enhanced in the absence of ERRalpha and that the number of precursor cells is not modified. The results above may reflect an effect of the absence of ERRalpha on osteoblast proliferation rather than on differentiation. To evaluate this hypothesis, we determined the growth capacities of bone marrow cells (Fig. 3D). ERRalphaKO cells displayed identical growth rate as wild-type cells, as estimated by determining cell number after 3 and 7 days in culture. However, under these conditions, ERRalphaKO cells still displayed a higher ALP expression as measured by staining and mRNA expression. We thus concluded that the absence of ERRalpha enhanced the osteoblastic differentiation of bone marrow cells without modifying their proliferation capacities. This is in agreement with recent results showing that the inhibition of ERRalpha expression in mammary cells does not modify proliferation [21]. Our results are in contrast with previous data suggesting that ERRalpha promotes osteoblast differentiation [34]. However, it is worth noting that our study analyzed femoral mesenchymal cells (which form endochondral bone, i.e. requiring a cartilage anlagen) derived from ERRalphaKO mice, whereas Bonnelye et al. [34] used transiently transfected rat calvarial cells (which form intramembranous bone). These methodological differences might account for the apparent discrepancies found between both studies. In contrast, our data are in agreement with published results in which MSCs originating from an independent ERRalphaKO strain were found more prone to differentiate into osteoblasts [35]. Interestingly this report also show that ERRalpha concomitantly promotes adipocyte differentiation of MSCs, suggesting that the receptor modulates an inverse relationship between adipogenic and osteogenic commitment of MSCs. In further support of our data, it is also worth noting that the closely related ERRgamma receptor has recently been found to inhibit BMP2-induced osteoblast differentiation in vitro as well as BMP2-induced ectopic bone formation in vivo[36]. Elevated osteoblast differentiation ex vivo in the absence of ERRalpha is furthermore consistent with the more elevated BFR found in vivo in ERRalphaKO mice. Furthermore, opn has been shown to inhibit bone mineralization [24]-[30]. A lower level of opn expression in the absence of ERRalpha could thus result in higher mineralization as observed in aging ERRalphaKO mice.
###end p 28
###begin title 29
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ex vivo</italic>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Ex vivo differentiation of bone marrow osteoblast precursors originating from ERRalphaKO mice.
###end title 29
###begin p 30
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 329 330 329 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 546 547 542 543 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 628 630 620 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 927 928 919 920 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
A) Upper panels: Alkaline phosphatase (ALP)- and von Kossa staining after 7 d and 21 d, respectively, in differentiation medium. Lower panel: expression of osteoblast differentiation markers measured by QPCR after 7 d in differentiation medium. Data are expressed relative to wild type level. Ocn: osteocalcin; opn: osteopontin. B) Time course of ALP expression after switch to differentation medium in wild type- (white bars) and ERRalphaKO- (black bars) originating cells measured by QPCR. Data are expressed relative to wild type level at d0. C) Rescue of the differentiation phenotype by infection with an ERRalpha-encoding vs a GFP-encoding adenovirus. Upper panel: ALP staining; lower panel: expression of osteoblast differentiation markers determined by QPCR. Adenoviruses were added together with the differentiation medium and the experiment was stopped after 7 d. Data are expressed relative to AdGFP infected cells. D) Proliferation of osteoblast precursors. Upper left panel: time course of cell number; lower left panel: time course of ALP staining; right panel: time course of ALP enzymatic activity relative to protein content. Time is indicated after switch to differentiation medium. All experiments were performed at least three times using female bone marrow. Staining views represent a single typical experiment; expression data and cell counting represent a typical experiment performed in triplicate with error bars indicating S.D.
###end p 30
###begin title 31
ERRalpha Deficiency Protects Females from Bone Loss Resulting from Sex Hormone Ablation
###end title 31
###begin p 32
###xml 583 590 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g004">Fig. 4A</xref>
###xml 615 622 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g004">Fig. 4B</xref>
###xml 899 906 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007942-g004">Fig. 4C</xref>
###xml 1141 1148 1129 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007942-t001">Table 1</xref>
###xml 274 279 <span type="species:ncbi:9606">women</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1135 1139 <span type="species:ncbi:10090">mice</span>
Normal aging causes a moderate bone loss as the result of a progressive imbalance between bone formation and bone resorption. This equilibrium is also disrupted in favor of bone resorption upon sex hormone deficiency which leads to a severe bone loss, as can be observed in women after menopause or in mice after ovariectomy. Since bone formation is more elevated in ERRalphaKO we hypothesized that this phenomenon might compensate for the remodeling imbalance induced by sex-hormone withdrawal. Gonadectomized wild type females showed an important decrease of relative bone volume (Fig. 4A) and trabecular number (Fig. 4B) four wks after surgery. Strikingly, none of these parameters were significantly affected in ovariectomized ERRalphaKO animals, indicating that cancellous bone was preserved in mutant mice. Bone formation rate was enhanced in wt females as marker of enhanced bone remodeling (Fig. 4C). In contrast, this parameter did not vary in ERRalphaKO mice according to the hormonal status. In males, orchidectomy resulted in similar variations in mineral density, bone volume and trabecular number in wild type and mutant mice (Table 1), indicating suggesting that bone was equally affected, independently of the genotype. We thus concluded that the absence of ERRalpha completely protects against the bone loss induced by deficiency in sex hormone action in females, but not in males.
###end p 32
###begin title 33
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Bone structural parameters of ovariectomized ERRalphaKO mice.
###end title 33
###begin p 34
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 91 92 91 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Bone volume fraction (BV/TV; A), trabecular number (TbN; B), and bone formation rate (BFR; C) were determined in the femur 4 wk after surgery (performed at 10 wk of age) in sham (white bars) or ovariectomized (black bars) wild type and ERRalphaKO mice. n: 8. Errors bars represent s.e.m. ns: not significant; *:p<0.05; *** p<0.005.
###end p 34
###begin p 35
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 205 207 201 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii</italic>
###xml 429 433 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Yoshitake1">[37]</xref>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
The mechanisms responsible for this phenomenon are not identified but it is tempting to speculate that i) the higher differentiation capacities of MSCs in osteoblasts in the absence of ERRalpha as well as ii) the low expression of opn in ERRalphaKO osteoblasts could be involved in sparing bone under estrogen deficiency challenge. Indeed, it has been shown that opn-deficient mice are resistant to ovariectomy-induced bone loss [37].
###end p 35
###begin p 36
###xml 408 415 400 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
In summary, our data show that the absence of ERRalpha leads to a resistance in age- as well as estrogen-deficiency-dependent bone loss exclusively in female mice. This finding may have important consequences for the treatment of osteoporosis following menopause, and will need careful investigation to unravel the mechanisms through which ERRalpha acts in osteoblast differentiation and bone mineralization in vivo.
###end p 36
###begin title 37
Materials and Methods
###end title 37
###begin title 38
Animals
###end title 38
###begin p 39
###xml 49 53 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Luo1">[38]</xref>
###xml 436 446 432 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 448 452 <span type="species:ncbi:10090">Mice</span>
ERRalphaKO animals have been described elsewhere [38]. All animal experiments were performed in the Plateau de Biologie Experimentale de la Souris (PBES; ENS Lyon) under Animal care procedures, conducted in accordance with the guidelines set by the European Community Council Directives (86/609/EEC) and approved by the local ethical committee. Animals were in C57black6 background and, except were stated, had access to food and water ad libitum. Mice were sacrificed by cervical dislocation at 10 a.m.
###end p 39
###begin p 40
For surgery, animals were anesthetized with sodium pentobarbital. Testes were ligatured and cut through an incision in the scrotum. Ovaries were removed through an incision in the flanks. Animals were sacrificied 4 wk after operation. Statistical significance was analyzed using one-way ANOVA.
###end p 40
###begin title 41
X-ray Micro-Computed Tomography Analysis
###end title 41
###begin p 42
3D microarchitecture of the femur was evaluated using a high-resolution (8 microm) microtomographic imaging system (eXplore Locus, GE, USA). A 3D region within the secondary spongiosa in the proximal metaphysis of the femur was reconstructed, beginning 500 microm proximal to the growth plate and extending to 1.5 mm. Cortical bone was reconstructed from a 1 mm thick region of interest centered on the diaphysis, 5 mm distal from the proximal growth plate. Morphometric parameters were computed using the Advanced Bone Analysis Microview Software (GE).
###end p 42
###begin title 43
Histomorphometric Analysis
###end title 43
###begin p 44
###xml 540 544 <span type="species:ncbi:10090">mice</span>
For histological analyses, undecalcified bones were fixed, deshydrated in ethanol solutions at 4degreesC and embedded in methyl-methacrylate according to standard protocols. For each femur, 7 microm thick longitudinal sections, parallel to the sagittal plane, were prepared. Bone sections were stained with von Kossa/van Giseon reagent, images were captured using a Nikon eclipse 80i microscope and analyzed using NIS Elements AR 2.30 software (Nikon). To determine bone formation parameters, calcein (10 mg/kg body weight) was injected to mice i.p. 5 and 2 d before sacrifice. Bone formation rate was calculated as interlabeled widths/interval time. To determine bone resorption parameters, sections were stained for tartrate-resistant acid phosphatase (TRAP). TRAP-positive multinucleated cells attached to bone were scored as osteoclasts and results were expressed as number of osteoclasts per trabecular bone perimeter. Bone-related degradation products from Collagen 1 (Ctx) in serum were measured by immunosorbent assay, using a RatLaps ELISA kit from Nordic Bioscience Diagnostics A/S (Herlev, Denmark), following the recommendations of the manufacturers. Measurements were performed after overnight fasting.
###end p 44
###begin title 45
Bone Marrow Cultures
###end title 45
###begin p 46
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 656 657 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1028 1029 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1055 1056 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1391 1395 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007942-Schreiber1">[39]</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:9913">calf</span>
Primary MSCs were collected from bone marrow of femur and tibia of 12-week old mice and cultured in six-well dishes (4x106 cells/well) in MEMalpha containing 10% fetal calf serum with 100 U/ml penicillin G and 100 microg/ml streptomycin. For osteoblastic differentiation, after 5 d of culture the medium was supplemented with 50 microg/ml L-ascorbic acid and 10 mM beta-glycerophosphate and replaced every 2 to 3 days for 3, 7, 14 or 21 days. Osteoblastic differentiation was evaluated by ALP staining and ALP enzymatic activity. For ALP staining, cells were rinsed twice with PBS, and then fixed with 4% (v/v) formaldehyde for 5 min. After 3 washes with H2O, cells were incubated 30 min with Fast Blue RR salt and Naphtol AS-MX Phosphate Alkaline solution 0,25% (Sigma Aldrich) in the dark. For ALP enzymatic activity measurement, cells were lysed with Lysis Buffer (50 mM Tris, HCl pH 7,5; 0,1% Triton-X100; 0,9% NaCl). Cell lysates were incubated with 0,2 M of Naphtol Alkaline solution (Sigma Aldrich) and the conversion of p-nitrophenyl phosphate to p-nitrophenol was spectrophotometrically determined and normalized to cellular protein content by using detergent compatible Bradford reagent (Pierce). For proliferation tests, viable cells were visually counted after resuspension and trypan blue coloration. Adenoviral vectors expressing GFP or ERRalpha have been previously described [39] and kindly donated by Anastasia Kralli.
###end p 46
###begin title 47
Expression Analysis
###end title 47
###begin p 48
RNAs were purified using Guanidinium thiocyanate/phenol/chloroforme extraction. Total RNAs were reverse transcribed using Superscript II retrotranscription kit (Invitrogen). Quantitative PCR were performed using the SYBR GREEN Jump Start kit (Sigma Aldrich) in duplicate on an ABI apparatus using standard procedure. Expression data were normalized to the expression of the 36b4 housekeeping gene. Sequence of the primers used in this study:
###end p 48
###begin p 49
###xml 6 32 6 32 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCTCCTTCTTCCAGGCTTT-3&#8242;</named-content>
###xml 37 64 37 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCCACCTTGTCTCCAGTCTTT-3&#8242;</named-content>
###xml 71 97 71 97 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCCTCCAGATCCTGACCAA-3&#8242;</named-content>
###xml 102 129 102 129 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCAGAGCCTGCTGGTCCTTA-3&#8242;</named-content>
###xml 141 167 137 163 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAAACGCCTCTGCCTGGTCT-3&#8242;</named-content>
###xml 172 198 168 194 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTCGATGCTCCCCTGGATG-3&#8242;</named-content>
###xml 205 231 201 227 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCTCACAGATGCCAAGCCC-3&#8242;</named-content>
###xml 236 262 232 258 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCGCCGGAGTCTGTTCACT-3&#8242;</named-content>
###xml 269 295 265 291 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTCCTTGCGCCACAGAATG-3&#8242;</named-content>
###xml 300 326 296 322 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGTCCATGTGGTCATGGCT-3&#8242;</named-content>
###xml 336 362 332 358 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACGTGCCCAGGCGTATTTC-3&#8242;</named-content>
###xml 367 393 363 389 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAACTGCCTGGGGTCTGAA-3&#8242;</named-content>
36b4: 5'-ACCTCCTTCTTCCAGGCTTT-3' and 5'-CCCACCTTGTCTCCAGTCTTT-3'; ALP: 5'-GCCCTCCAGATCCTGACCAA-3' and 5'- GCAGAGCCTGCTGGTCCTTA-3'; ERRalpha: 5'-CAAACGCCTCTGCCTGGTCT-3' and 5'-ACTCGATGCTCCCCTGGATG-3'; OCN: 5'-ACCTCACAGATGCCAAGCCC-3' and 5'-AGCGCCGGAGTCTGTTCACT-3'; OPN: 5'-TCTCCTTGCGCCACAGAATG-3' and 5'-TCGTCCATGTGGTCATGGCT-3'; Runx-2: 5'-GACGTGCCCAGGCGTATTTC-3' and 5'-GGAACTGCCTGGGGTCTGAA-3'.
###end p 49
###begin p 50
We thank Anastasia Kralli for the gift of adenovirus vectors. We thank the personnel of the PBES, ENS Lyon, for helping in performing animal experimentations.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
Osf2/Cbfa1, a transcriptional regulator of osteoblast differentiation.
###end article-title 52
###begin article-title 53
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.
###end article-title 53
###begin article-title 54
Regulation of osteoblast differentiation by transcription factors.
###end article-title 54
###begin article-title 55
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.
###end article-title 55
###begin article-title 56
Osteoclast precursors, RANKL/RANK, and immunology.
###end article-title 56
###begin article-title 57
RANKL-RANK signaling in osteoclastogenesis and bone disease.
###end article-title 57
###begin article-title 58
The molecular understanding of osteoclast differentiation.
###end article-title 58
###begin article-title 59
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
###end article-title 59
###begin article-title 60
Functions of RANKL/RANK/OPG in bone modeling and remodeling.
###end article-title 60
###begin article-title 61
Mechanisms of sex steroid effects on bone.
###end article-title 61
###begin article-title 62
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
###end article-title 62
###begin article-title 63
The nuclear receptor factbook.
###end article-title 63
###begin article-title 64
Orphan nuclear receptors: from gene to function.
###end article-title 64
###begin article-title 65
Identification of a new class of steroid hormone receptors.
###end article-title 65
###begin article-title 66
The NR3B subgroup: an ovERRview.
###end article-title 66
###begin article-title 67
Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand.
###end article-title 67
###begin article-title 68
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Expression of the estrogen related receptor 1 (ERR-1) orphan receptor during mouse development.
###end article-title 68
###begin article-title 69
Transcriptional control of energy homeostasis by the estrogen related receptors.
###end article-title 69
###begin article-title 70
ERRalpha: a metabolic function for the oldest orphan.
###end article-title 70
###begin article-title 71
Estrogen-related receptors as emerging targets in cancer and metabolic disorders.
###end article-title 71
###begin article-title 72
Modulating ERRalpha activity inhibits cell proliferation.
###end article-title 72
###begin article-title 73
The ERR-1 orphan receptor is a transcriptional activator expressed during bone development.
###end article-title 73
###begin article-title 74
###xml 127 132 <span type="species:ncbi:9606">women</span>
A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women.
###end article-title 74
###begin article-title 75
Osteopontin, a possible anchor of osteoblasts to bone.
###end article-title 75
###begin article-title 76
Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alphavbeta3 potentiate bone resorption.
###end article-title 76
###begin article-title 77
Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin.
###end article-title 77
###begin article-title 78
Osteopontin.
###end article-title 78
###begin article-title 79
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone.
###end article-title 79
###begin article-title 80
Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency.
###end article-title 80
###begin article-title 81
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Osteopontin deficiency and aging on nanomechanics of mouse bone.
###end article-title 81
###begin article-title 82
Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha.
###end article-title 82
###begin article-title 83
Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta.
###end article-title 83
###begin article-title 84
Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner.
###end article-title 84
###begin article-title 85
The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro.
###end article-title 85
###begin article-title 86
Absence of estrogen receptor related alpha increases osteoblastic differentiation and cancellous bone mineral density.
###end article-title 86
###begin article-title 87
The orphan nuclear receptor Estrogen-receptor-Related Receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation.
###end article-title 87
###begin article-title 88
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.
###end article-title 88
###begin article-title 89
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha.
###end article-title 89
###begin article-title 90
The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.
###end article-title 90
###begin p 91
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 91
###begin p 92
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Inserm (Programme National de Recherche sur les maladies osteo-articulaires), Agence Nationale pour la Recherche (grant ANR-08-GENOPAT-012). C.T. has been funded by Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 92

